Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-11-003244)

Filing Details

Accession Number:: 0001209191-11-003244
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-01-14 16:35:57
Reporting Period:: 2011-01-13

Filing Date:: 2011-01-14
Accepted Time:: 2011-01-14 16:35:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
816284	Celgene Corp	CELG	Pharmaceutical Preparations (2834)	222711928

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1247015	J Sol Barer	C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-01-13	108,534	$26.35	767,392	No	4	M	Direct
Common Stock	Disposition	2011-01-13	75,200	$57.38	692,192	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2011-01-13	108,534	$0.00	108,534	$26.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2011-01-17	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	61,281	Indirect	401(k) Plan

Footnotes

This sale was executed pursuant to a prearranged trading plan compliant with Rule 10b5-1.
The option was fully exercisable.
The option was issued pursuant to the Company's 2008 Stock Incentive Plan.